| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 331.18M | 193.13M | 141.25M | 165.17M | 7.82M |
| Gross Profit | 218.30M | 112.18M | 38.68M | 57.25M | 2.51M |
| EBITDA | 246.61M | 129.38M | 46.94M | 85.06M | -1.69M |
| Net Income | 199.65M | 91.17M | 10.87M | 25.40M | -2.51M |
Balance Sheet | |||||
| Total Assets | 406.34M | 279.07M | 259.11M | 223.25M | 263.22M |
| Cash, Cash Equivalents and Short-Term Investments | 137.50M | 12.04M | 10.39M | 6.69M | 1.62M |
| Total Debt | 2.59M | 8.07M | 14.35M | 43.20M | 91.56M |
| Total Liabilities | 27.03M | 77.82M | 146.92M | 136.47M | 188.05M |
| Stockholders Equity | 379.32M | 201.25M | 111.39M | 86.78M | 75.17M |
Cash Flow | |||||
| Free Cash Flow | 183.85M | 57.66M | 35.41M | 55.71M | -63.73M |
| Operating Cash Flow | 188.92M | 61.76M | 63.84M | 84.39M | -22.36M |
| Investing Cash Flow | -28.09M | -12.87M | -38.45M | -30.55M | -44.75M |
| Financing Cash Flow | -32.82M | -44.70M | -25.07M | -48.43M | 37.22M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
88 Outperform | C$873.21M | 3.11 | 65.00% | 2.78% | 71.23% | 115.27% | |
78 Outperform | C$981.60M | 8.63 | 33.97% | ― | 75.17% | 73.99% | |
76 Outperform | C$1.57B | 6.59 | 21.51% | ― | 57.59% | 11.36% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
53 Neutral | C$1.72B | -30.36 | -58.35% | ― | ― | -74.71% | |
49 Neutral | C$574.28M | 23.65 | -3.94% | ― | -0.97% | -40.86% |